Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical dexamethasone spray after total thyroidectomy
IRCT20230323057764N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in thyroid cancer (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Blood calcium level. Started May 2023; status: completed.
02
Drugs
dexamethasone
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on IRCT20230323057764N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230323057764N1.